The history of Viagra, initially marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical sector. Despite its initial success and generation of billions in revenue , the exclusivity end has opened the floodgates for generic medications, significantly reducing income opportunities. This transition raises co